PARIS, France—For patients undergoing transcatheter valve-in-valve (ViV) procedures to treat a small failed aortic bioprosthesis, self-expanding devices outperform balloon-expandable devices at 30 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback